Tenet Healthcare Corporation New (THC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 28, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the THC SEC filings page.
Tenet Healthcare Corporation New (THC) reported $21.8B in revenue over the twelve months to Jun 30, 2026, up 5.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Tenet’s revenue is steady, but profitability is volatile; the company now relies on a less leveraged balance sheet and stronger cash conversion.
The key disconnect is in FY2025: operating cash flow increased72.9% while net income fell56.0% . Free-cash-flow margin nevertheless expanded6.5 pp , and operating cash flow reached251.6% of net income, indicating that reported earnings and cash generation measured very different aspects of the year.
Revenue grew
The balance sheet has been structurally reworked: liabilities were
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Tenet Healthcare Corporation New's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Tenet Healthcare Corporation New has an operating margin of 16.5%, meaning the company retains $16 of operating profit per $100 of revenue. This strong profitability earns a score of 76/100, reflecting efficient cost management and pricing power. This is down from 28.8% the prior year.
Tenet Healthcare Corporation New's revenue grew a modest 3.1% year-over-year to $21.3B. This slow but positive growth earns a score of 37/100.
Tenet Healthcare Corporation New has elevated debt relative to equity (D/E of 3.10), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 27/100, reflecting increased financial risk.
Tenet Healthcare Corporation New's current ratio of 1.76 indicates adequate short-term liquidity, earning a score of 52/100. The company can meet its near-term obligations, though with limited headroom.
Tenet Healthcare Corporation New has a free cash flow margin of 11.9%, earning a moderate score of 63/100. The company generates positive cash flow after capital investments, but with room for improvement.
Tenet Healthcare Corporation New earns a strong 33.3% return on equity (ROE), meaning it generates $33 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is down from 76.7% the prior year.
Tenet Healthcare Corporation New scores 2.08, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from revenue of $21.3B against total assets of $29.7B. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Tenet Healthcare Corporation New passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, Tenet Healthcare Corporation New generates $2.52 in operating cash flow ($3.5B OCF vs $1.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Tenet Healthcare Corporation New earns $4.27 in operating income for every $1 of interest expense ($3.5B vs $821.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
Tenet Healthcare Corporation New generated $5.6B in revenue in Q2 2026. This represents an increase of 6.8% from the same quarter a year earlier. Against the prior quarter it is up 4.8%.
Tenet Healthcare Corporation New's EBITDA was $1.7B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 66.4% from the same quarter a year earlier. Against the prior quarter it is up 12.5%.
Tenet Healthcare Corporation New reported $826.0M in net income in Q2 2026. This represents an increase of 186.8% from the same quarter a year earlier. Against the prior quarter it is up 17.7%.
Tenet Healthcare Corporation New earned $9.84 per diluted share (EPS) in Q2 2026. This represents an increase of 213.4% from the same quarter a year earlier. Against the prior quarter it is up 22.8%.
Cash & Balance Sheet
Tenet Healthcare Corporation New generated $417.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 43.9% from the same quarter a year earlier. Against the prior quarter it is down 71.5%.
Tenet Healthcare Corporation New held $2.2B in cash against $13.1B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Tenet Healthcare Corporation New's operating margin was 26.7% in Q2 2026, reflecting core business profitability. This is up 11.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.
Tenet Healthcare Corporation New's net profit margin was 14.7% in Q2 2026, showing the share of revenue converted to profit. This is up 9.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.
Tenet Healthcare Corporation New's quarterly ROE was 17.7% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 10.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.
Not reported for Q2 2026.
Capital Allocation
Tenet Healthcare Corporation New spent $1.0B on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 39.5% from the same quarter a year earlier. Against the prior quarter it is up 227.7%.
Tenet Healthcare Corporation New invested $168.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 13.0% from the same quarter a year earlier. Against the prior quarter it is down 6.7%.
Not reported for Q2 2026.
THC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.6B+6.8% | $5.4B+2.8% | $5.5B+8.9% | $5.3B+3.2% | $5.3B+3.2% | $5.2B-2.7% | $5.1B-6.0% | $5.1B+1.2% |
| Operating Income | $1.5B+82.4% | $1.3B+37.4% | $853.0M+3.9% | $889.0M-18.4% | $823.0M+8.1% | $943.0M-71.3% | $821.0M+11.7% | $1.1B+91.7% |
| EBITDA | $1.7B+66.4% | $1.5B+32.7% | $1.1B+6.9% | $1.1B-14.7% | $1.0B+6.4% | $1.1B-67.1% | $1.0B+6.6% | $1.3B+63.9% |
| Interest Expense | $204.0M-1.0% | $205.0M+0.5% | $205.0M+1.0% | $206.0M+2.0% | $206.0M+1.5% | $204.0M-6.4% | $203.0M-10.6% | $202.0M-11.0% |
| Income Tax | $295.0M+145.8% | $226.0M+58.0% | $37.0M-55.4% | $133.0M-44.8% | $120.0M+9.1% | $143.0M-80.9% | $83.0M+31.7% | $241.0M+205.1% |
| Net Income | $826.0M+186.8% | $702.0M+72.9% | $371.0M+16.7% | $342.0M-27.5% | $288.0M+11.2% | $406.0M-81.1% | $318.0M+30.3% | $472.0M+367.3% |
| EPS (Basic) | $9.89+213.0% | $8.09+87.7% | $4.24+22.5% | $3.89-21.1% | $3.16+18.8% | $4.31-80.0% | $3.46+43.6% | $4.93+398.0% |
| EPS (Diluted) | $9.84+213.4% | $8.01+87.6% | $4.21+22.7% | $3.86-21.1% | $3.14+18.9% | $4.27-80.0% | $3.43+49.1% | $4.89+420.2% |
| Diluted Shares (Avg) | 84M-8.5% | 88M-7.8% | N/A | 89M-8.3% | 92M-6.8% | 95M-5.5% | N/A | 97M-7.4% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses.
THC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.7B+6.9% | $31.2B+6.7% | $29.7B+2.6% | $29.4B+0.2% | $28.7B-1.9% | $29.2B+1.1% | $28.9B+2.2% | $29.4B+6.5% |
| Current Assets | $7.8B+7.2% | $8.4B+5.6% | $7.8B+2.2% | $7.8B-10.8% | $7.3B-8.3% | $7.9B+1.2% | $7.7B+7.2% | $8.8B+37.7% |
| Cash & Equivalents | $2.2B-17.3% | $3.0B-1.1% | $2.9B-4.5% | $3.0B-27.3% | $2.6B-8.9% | $3.0B+20.9% | $3.0B+145.8% | $4.1B+288.4% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $338.0M0.0% | $343.0M-0.3% | $348.0M+0.6% | $346.0M-2.8% | $338.0M-11.5% | $344.0M-12.9% | $346.0M-15.8% | $356.0M-13.8% |
| Accounts Receivable | $2.6B+3.0% | $2.6B-0.5% | $2.6B+1.1% | $2.5B-3.1% | $2.5B-10.1% | $2.6B-16.8% | $2.5B-13.0% | $2.6B-10.3% |
| Long-Term Investments | $0n/m | $0n/m | $59.0M+18.0% | $0n/m | $0n/m | $0n/m | $50.0M+4.2% | $0n/m |
| Goodwill | $11.4B+4.6% | $11.4B+5.6% | $11.2B+4.7% | $11.2B+5.4% | $10.9B+1.3% | $10.8B+2.1% | $10.7B+3.7% | $10.6B+1.7% |
| Total Liabilities | $22.0B+7.7% | $22.4B+8.6% | $20.7B+1.5% | $20.7B-2.7% | $20.4B-4.7% | $20.6B-3.1% | $20.4B-10.6% | $21.3B-5.0% |
| Current Liabilities | $5.6B+30.3% | $6.2B+38.2% | $4.5B+3.5% | $4.6B-17.7% | $4.3B-22.2% | $4.5B-17.8% | $4.3B-9.5% | $5.5B+25.0% |
| Non-Current Liabilities | $16.4B+1.8% | $16.2B+0.4% | $16.2B+1.0% | $16.2B+2.5% | $16.1B+1.4% | $16.1B+2.0% | $16.1B-10.9% | $15.8B-12.3% |
| Long-Term Debt | $13.1B0.0% | $13.1B+0.4% | $13.1B+0.1% | $13.1B+2.6% | $13.1B+2.5% | $13.1B+2.4% | $13.1B-12.1% | $12.8B-14.3% |
| Total Equity | $4.7B+24.2% | $4.8B+15.1% | $4.2B+1.2% | $4.0B+4.7% | $3.7B+7.9% | $4.2B+21.1% | $4.2B+159.4% | $3.8B+161.9% |
| Retained Earnings | $5.9B+60.5% | $5.1B+49.9% | $4.4B+46.8% | $4.0B+50.3% | $3.7B+66.9% | $3.4B+74.3% | $3.0Bn/m | $2.7Bn/m |
THC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $585.0M-37.5% | $1.6B+101.3% | $731.0Mn/m | $1.1B+1.2% | $936.0M+25.3% | $815.0M+39.1% | -$331.0M-140.2% | $1.0B+107.8% |
| Depreciation & Amortization | $215.0M+3.4% | $229.0M+11.2% | $231.0M+19.7% | $218.0M+4.3% | $208.0M0.0% | $206.0M-1.0% | $193.0M-10.6% | $209.0M-6.7% |
| Stock-Based Compensation | N/A | $25.0M+19.0% | N/A | N/A | N/A | $21.0M+23.5% | N/A | N/A |
| Capital Expenditures | $168.0M-13.0% | $180.0M+4.0% | $364.0M+10.3% | $280.0M+29.6% | $193.0M+33.1% | $173.0M-27.9% | $330.0M+58.7% | $216.0M+22.7% |
| Free Cash Flow | $417.0M-43.9% | $1.5B+127.6% | $367.0Mn/m | $778.0M-6.2% | $743.0M+23.4% | $642.0M+85.5% | -$661.0M-207.3% | $829.0M+153.5% |
| Investing Cash Flow | -$203.0Mn/m | -$317.0Mn/m | -$389.0Mn/m | -$385.0M-157.7% | -$314.0Mn/m | -$187.0M-105.6% | -$372.0Mn/m | $667.0Mn/m |
| Financing Cash Flow | -$1.2Bn/m | -$1.2Bn/m | -$434.0Mn/m | -$323.0Mn/m | -$996.0Mn/m | -$648.0Mn/m | -$372.0Mn/m | -$498.0Mn/m |
| Share Buybacks | $1.0B+39.5% | $318.0M-8.6% | $198.0Mn/m | $93.0M-25.0% | $747.0M+176.7% | $348.0M+25.2% | $0-100.0% | $124.0Mn/m |
Not reported in any period shown, so not listed: Dividends Paid.
THC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 26.7%+11.1pp | 24.1%+6.1pp | 15.4%-0.8pp | 16.8%-4.4pp | 15.6%+0.7pp | 18.1%-43.1pp | 16.2%+2.6pp | 21.2%+10.0pp |
| Net Margin | 14.7%+9.2pp | 13.1%+5.3pp | 6.7%+0.4pp | 6.5%-2.7pp | 5.5%+0.4pp | 7.8%-32.3pp | 6.3%+1.8pp | 9.2%+7.2pp |
| Return on Equity | 17.7%+10.1pp | 14.6%+4.9pp | 8.8%+1.2pp | 8.5%-3.8pp | 7.7%+0.2pp | 9.7%-52.6pp | 7.6%-7.5pp | 12.3%+5.4pp |
| Return on Assets | 2.7%+1.7pp | 2.3%+0.9pp | 1.3%+0.2pp | 1.2%-0.5pp | 1.0%+0.1pp | 1.4%-6.0pp | 1.1%+0.2pp | 1.6%+1.2pp |
| Current Ratio | 1.41-0.3x | 1.36-0.4x | 1.760.0x | 1.71+0.1x | 1.71+0.3x | 1.78+0.3x | 1.78+0.3x | 1.58+0.1x |
| Debt-to-Equity | 2.81-0.7x | 2.73-0.4x | 3.100.0x | 3.26-0.1x | 3.49-0.2x | 3.13-0.6x | 3.14-6.1x | 3.33-6.8x |
| Liabilities-to-Equity | 4.72-0.7x | 4.64-0.3x | 4.910.0x | 5.16-0.4x | 5.44-0.7x | 4.92-1.2x | 4.89-9.3x | 5.55-9.8x |
| Asset Turnover | 0.180.0x | 0.170.0x | 0.190.0x | 0.180.0x | 0.180.0x | 0.180.0x | 0.180.0x | 0.170.0x |
| FCF Margin | 7.4%-6.7pp | 27.2%+14.9pp | 6.6%+19.7pp | 14.7%-1.5pp | 14.1%+2.3pp | 12.3%+5.8pp | -13.0%-24.4pp | 16.2%+9.7pp |
Not reported in any period shown, so not listed: Gross Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Tenet Healthcare Corporation New THC | FY2025 | $21.3B | $1.4B | 6.6% | $21.6B | 56/100 |
| Fresenius Medical Care AG FMS | FY2025 | $23.0B | $1.1B | 5.0% | $12.0B | 49/100 |
| Universal Health Services, Inc. UHS | FY2025 | $17.4B | $1.5B | 8.6% | $10.1B | 53/100 |
| Encompass Health Corporation EHC | FY2025 | $5.9B | $566.2M | 9.5% | $12.0B | 59/100 |
| HCA Healthcare, Inc. HCA | FY2025 | $75.6B | $6.8B | 9.0% | $100.3B | 62/100 |
| DaVita Inc. DVA | FY2025 | $13.6B | $746.8M | 5.5% | $11.7B | 56/100 |
Where Tenet Healthcare Corporation New Ranks
Frequently Asked Questions
What is Tenet Healthcare Corporation New's annual revenue?
Tenet Healthcare Corporation New (THC) reported $21.3B in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Tenet Healthcare Corporation New's revenue growing?
Tenet Healthcare Corporation New (THC) revenue grew by 3.1% year-over-year, from $20.7B to $21.3B in fiscal year 2025.
Is Tenet Healthcare Corporation New profitable?
Yes, Tenet Healthcare Corporation New (THC) reported a net income of $2.2B over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $1.4B, with a net profit margin of 6.6%.
What is Tenet Healthcare Corporation New's EBITDA?
Tenet Healthcare Corporation New (THC) had EBITDA of $4.4B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Tenet Healthcare Corporation New have?
As of fiscal year 2025, Tenet Healthcare Corporation New (THC) had $2.9B in cash and equivalents against $13.1B in long-term debt.
What is Tenet Healthcare Corporation New's operating margin?
Tenet Healthcare Corporation New (THC) had an operating margin of 16.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Tenet Healthcare Corporation New's net profit margin?
Tenet Healthcare Corporation New (THC) had a net profit margin of 6.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Tenet Healthcare Corporation New's return on equity (ROE)?
Tenet Healthcare Corporation New (THC) has a return on equity of 33.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Tenet Healthcare Corporation New's free cash flow?
Tenet Healthcare Corporation New (THC) generated $2.5B in free cash flow during fiscal year 2025. This represents a 126.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Tenet Healthcare Corporation New's operating cash flow?
Tenet Healthcare Corporation New (THC) generated $3.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Tenet Healthcare Corporation New's total assets?
Tenet Healthcare Corporation New (THC) had $29.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Tenet Healthcare Corporation New's capital expenditures?
Tenet Healthcare Corporation New (THC) invested $1.0B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Tenet Healthcare Corporation New's current ratio?
Tenet Healthcare Corporation New (THC) had a current ratio of 1.76 as of fiscal year 2025, which is generally considered healthy.
What is Tenet Healthcare Corporation New's debt-to-equity ratio?
Tenet Healthcare Corporation New (THC) had a debt-to-equity ratio of 3.10 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Tenet Healthcare Corporation New's liabilities-to-equity ratio?
Tenet Healthcare Corporation New (THC) had a liabilities-to-equity ratio of 4.91 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Tenet Healthcare Corporation New's return on assets (ROA)?
Tenet Healthcare Corporation New (THC) had a return on assets of 4.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Tenet Healthcare Corporation New's P/E ratio?
Tenet Healthcare Corporation New (THC) trades at 9.6x earnings, its market capitalization divided by $2.2B net income, trailing 12 months to June 30, 2026. The market capitalization is $21.6B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Tenet Healthcare Corporation New's price-to-sales ratio?
Tenet Healthcare Corporation New (THC) trades at 1.0x sales, its market capitalization divided by $21.8B revenue, trailing 12 months to June 30, 2026. The market capitalization is $21.6B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Tenet Healthcare Corporation New's Altman Z-Score?
Tenet Healthcare Corporation New (THC) has an Altman Z-Score of 2.08, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Tenet Healthcare Corporation New's Piotroski F-Score?
Tenet Healthcare Corporation New (THC) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Tenet Healthcare Corporation New's earnings high quality?
Tenet Healthcare Corporation New (THC) has an earnings quality ratio of 2.52x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Tenet Healthcare Corporation New cover its interest payments?
Tenet Healthcare Corporation New (THC) has an interest coverage ratio of 4.27x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Tenet Healthcare Corporation New?
Tenet Healthcare Corporation New (THC) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.